EDLB- Illumina Inc, OEM maintenance for the Illumina MiSeq i100 Plus Sequencer
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Centers for Disease Control and Prevention (CDC) intends to award a sole-source, Firm-Fixed-Price contract to Illumina, Inc. for a five-year maintenance service agreement for the Illumina MiSeq i100 Plus Sequencer. This is a Special Notice/Notice of Intent, and interested parties capable of providing equivalent services are invited to submit capability statements.
Purpose & Scope
The CDC requires a five-year maintenance service agreement for its Illumina MiSeq i100 Plus Sequencer (S/N: SH00687), located in Atlanta, GA. This instrument is critical for the CDC's PulseNet foodborne disease surveillance network, supporting whole-genome sequencing for rapid identification and investigation of foodborne disease outbreaks. The required maintenance agreement covers preventative maintenance, OEM-certified repair services, technical support, software and firmware updates, replacement parts, labor, travel, reagent replacement for hardware failures, and Field Application Scientist (FAS) support.
Contract Details
- Type: Sole Source, Firm-Fixed-Price contract.
- Proposed Vendor: Illumina, Inc.
- Estimated Value: $68,862.65
- Period of Performance: Base Year plus Four Option Years (totaling five years).
- Product Service Code: J066 (Maintenance, Repair And Rebuilding Of Equipment: Instruments And Laboratory Equipment).
Justification for Sole Source
The CDC justifies this sole-source acquisition under FAR 12.102 and 41 USC 1901, citing that Illumina, Inc. is the Original Equipment Manufacturer (OEM) and the only known source capable of providing the required comprehensive, OEM-certified maintenance and support services. Market research confirmed Illumina's exclusive rights to proprietary diagnostic software, firmware updates, factory calibration procedures, and certified OEM replacement parts. The use of non-OEM services would risk warranty loss, degraded performance, extended downtime, and interruption of critical operations.
Submission & Evaluation
This notice is not a request for competitive quotations. However, interested organizations that believe they can meet the requirement are invited to submit a capability statement. These statements will be evaluated to determine if a competitive procurement is warranted.
Eligibility / Set-Aside
Not applicable, as this is a sole-source justification and notice of intent.
Key Dates & Contacts
- Capability Statements Due: June 22, 2026, at 10:00 a.m. Eastern Time.
- Primary Contact: Ashley Williams (dal3@cdc.gov).
- Secondary Contact: Sheena Delaine (kpz5@cdc.gov).